Truthout
Drug Pricing
Drugmakers Master Rolling Out Their Own Generics to Stifle Competition
Big brand companies producing authorized generics maximize their profits by appearing to compete with themselves.
Senate Finance Committee Deals Blow to Big Pharma
The bill aims to reduce drug prices for seniors and save taxpayers billions on government-run health care programs.
High Cost of Insulin Sends Americans to Canada Where It’s 90 Percent Cheaper
Between 2012 and 2016, the cost of insulin nearly doubled.
A Former Industry Insider Reveals How Drug Companies Jack Up Prices
Frances Leath no longer works in management for Eli Lilly and Company, but she keeps tabs on the company.
Replace Patent Monopolies With Direct Public Funding for Drug Research
The savings in drug costs with generics would more than pay for funding the research.
Would a Compromise on the Drug Pricing Bill Be a Victory or Defeat?
President Trump has reached an agreement on the outlines of a prescription drug bill with House Speaker Nancy Pelosi.
How Poor Oversight and Fraud in Generic Drug Industry Threatens Patients’ Health
Manufacturers are cutting corners at the cost of quality and safety.
The Reality Behind the “Surging” US Economy
The average American's hourly pay rose just six cents in April this year, and only four cents the month before that.
Big Pharma Is Running an Elaborate Shell Game — and Lives Are at Stake
Big Pharma’s gambit to deflect attention and blame is dishonest and inaccurate.
Pressured by Grassroots Activism, Eli Lilly Announces Half-Price Insulin
Lilly announced last week that it is rolling out a half-priced, generic version of the medicine Humalog.